Join us today at #RESI, as one of the #therapeutics finalists (Wednesday 21, 2 - 2:50pm). Our CEO is also one of the speakers at the #Entrepreneur Workshop, Wednesday 21 from 11 - 11:50 am.
Join our pitch, and come by our pitch company poster at Easel #48! #RESIBoston
30 startups have been selected as semifinalists for the NEXT Venture Summit. Ten of the 30 semi-finalists were SCRA Companies. These companies represent a broad cross-section of industries and are among the most venture-ready startups in the region.
Meet our newest #teammember and Senior R&D Manager, Sonia Golombek. She is such a great addition to our team and will help bringing our #technology to market!
https://t.co/zL7A9QuXtf
Congratulations to RESI Boston Innovator’s Pitch Challenge finalist, @elastrin! CEO, Matthias Breugelmans, will pitch to a panel of #investors September 21-22. Join RESI to cheer on our IPC finalists:
Cardiologists predict a serious rise in CVD rates by 2060. Fortunately, SCBIO investor, @elastrin is taking action. Their nanotechnology will help restore elastic tissue, reversing damage to the CV System. https://t.co/Lj5UCQGE81
#sclifesciences#biotech#cardiovascular
We will be at DxPx Conference at AACC in Chicago! Contact Matthias or book your meeting here: https://t.co/zwN8BnneRO to discover more about our #technology. He is also one of the speakers at #RejuvenationStartupSummit, don´t miss out this opportunity to meet our team. #LONGEVITY
Watch Douglas Mulhall, one of Elastrin Therapeutics founders, talk about #epigenetics and how our researchers are developing a new way to reverse heart disease damage in arteries (from the series Local News LIVE) via this link -> https://t.co/qxadttM2n8
#biotech#rejuvenation
@elastrin, an SC Launch Inc Portfolio Company, announced the closing of its $10 million funding round, led by @Kizoo, Starbloom Capital, and SC Launch Inc. Congrats @elastrin! 👏👏👏 Read the full press release: https://t.co/qAvoYqQVUR
Proud to lead this $10M round at Elastrin to boost the development of therapeutics that render calcified tissue and organs supple again and start clinical trials in humans in 2023.
https://t.co/wIybghdnze
Proud to announce the closing of our $10 Million #fundinground, led again by @Kizoo, completed by SC Launch Inc and Starbloom Capital. Thanks to all our investors, supporters and our whole team!
Read more: https://t.co/XUCnjGbHyb